Diagnostic and Treatment Implications of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.
Nonalcoholic fatty liver disease (NAFLD) affects 75 to 100 million adults in the United States and is the leading cause of chronic liver disease worldwide, fueled by the rising epidemic of obesity and metabolic syndrome. NAFLD is the hepatic manifestation of metabolic syndrome; thus, accurately asse...
| Publicado en: | Gastroenterology & Hepatology Vol. 15; no. 2; pp. 83 - 90 |
|---|---|
| Autores principales: | , , |
| Formato: | tables/charts Journal Article |
| Publicado: |
Gastro-Hep Communications, Inc
Feb2019
|
| Acceso en línea: | Ver este registro en EBSCOhost |